NEW YORK () -- Shares of Lantheus Holdings () were spiking 10.36% to $9.10 on heavy trading volume mid-afternoon Monday as Jefferies raised its price target on the North Billerica, MA-based diagnostic medical imaging agents company to $12 from $8 this morning.
The firm maintained its "buy" rating and noted that the company's recent product success, available cash flow and pending partnerships are all positives for the stock.
Lantheus' ultrasound contrast agent, called...
More